Post by Bristol Myers Squibb on X
Bristol Myers Squibb@bmsnews
X#MEDIA: The U.S. FDA approved an update to the required echo monitoring for our first-in-class treatment for adults living with symptomatic obstructive #HypertrophicCardiomyopathy: t.co
28 likes29 repliesPosted Apr 18, 2025